Patent US3969508A successfully refreshed from Google Patents.
US3969508A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Lowering the concentration of plasma triglycerides
Assignee: GlaxoSmithKline LLC
•
Filing: 1974-11-27
•
Granted: 1976-07-13
•
Expires: 1994-11-27
Abstract
Abstract Hypolipidemic compositions containing 4-(2-thenoyl)-2,3-dichlorophenoxyacetic acid, its alkali metal salts or pharmaceutically acceptable base addition salts and methods of producing hypolipidemic activity by administering said compound. Combinations with other useful agents are also disclosed.
Inventors
- 👤 Nicholas W. DiTullio
- 👤 Charles P. Lowman
- 👤 Alfred R. Maass
- 👤 Harry L. Saunders
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-28 11:03
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/38; A61K31/395; A61K31/40; A61K31/435; A61K31/47; A61K31/475; A61K31/495; A61K31/505; A61K31/519; A61K31/525
Claims Analysis
Total Claims: 6
Claim 1
Independent Claim
54 words
A method of lowering the concentration of plasma triglycerides in a hyperlipidemic subject, which comprises administering internally to said subject a nontoxic amount, sufficient to lower said triglyceride concentration, of the compound 4-(2-thenoyl)-2,3-dichlorophenoxyacetic acid, an alkali metals salt of said acid or a pharmaceutically acceptable addition salt of said acid formed with a base.
Claim 2
Independent Claim
54 words
A method of lowering the concentration of plasma triglycerides in a hyperlipidemic subject, which comprises administering internally to said subject a nontoxic amount, sufficient to lower said triglyceride concentration, of the compound 4-(2-thenoyl)-2,3-dichlorophenoxyacetic acid, an alkali metals salt of said acid or a pharmaceutically acceptable addition salt of said acid formed with a base.
Claim 3
Dependent Claim
24 words
The method of claim 1 in which a daily dosage of from about 200 mg. to about 2000 mg. of active ingredient is administered.
Claim 4
Dependent Claim
29 words
The method of claim 1 in which dosage units containing from about 100 mg. to about 500 mg. of active ingredient are administered from 2 to 4 times daily.
Claim 5
Dependent Claim
20 words
The method of claim 1 in which the active ingredient is administered with a pharmaceutical carrier in dosage unit form.
Claim 6
Dependent Claim
11 words
The method of claim 4 in which the administration is orally.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1979-07-13 | 1980-01-12 | 1980-07-13 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1983-07-13 | 1984-01-12 | 1984-07-13 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1987-07-13 | 1988-01-12 | 1988-07-13 | $7700.00 | Window Closed / Lapsed |